Chemomab Therapeutics CMMB
NASDAQ CMMB
$1.19 -0.42 (-26.09%)
At close: Sep 30, 2026 · 4:00 PM EDT

Chemomab Therapeutics (CMMB) Other financing activities (2018 - 2023)

Updated

Chemomab Therapeutics' Other financing activities came in at $3.99 million for Q3 2023, down 34.7% from $6.12 million a year earlier.

Analysis

Chemomab Therapeutics (CMMB) Other financing activities (2018 - 2023) Analysis & Trends

Over the trailing twelve months to Sep 30, 2023, Chemomab Therapeutics reported Other financing activities of $11.22 million, up 104.4% year-over-year; for FY2018, it was -$641,000.

  • Going back by year, Other financing activities was $259,000 in FY2017 (+370.9%) and $55,000 in FY2016.
  • The Q3 2023 figure represents the lowest quarterly Other financing activities since Q4 2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 Chemomab Therapeutics 11.58 Mn 11.58 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 3.99 Mn
Sep 30, 2022 6.12 Mn
Dec 31, 2018 1.11 Mn
Sep 30, 2018 -1.74 Mn
API Access

Chemomab Therapeutics Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=CMMB&period=max&api_key=YOUR_API_KEY